Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03951363 · ClinicalTrials.gov registry record · NA
iControl Chronic Kidney Disease
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03951363: Clinical Trial NA study, sponsored by Duke University.
NCT03951363 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03951363, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The proposed study is responsive to the call for obtaining enhanced preliminary data for an external grant resubmission. The goal is to demonstrate a novel approach using digital health tools to help preserve kidney function. The investigators aim to adapt a previous behavioral intervention and conduct formative testing among patients with CKD. Specifically, the investigators will: Aim 1: Modify an existing technology platform to build the iControl CKD system and adapt intervention content to reflect behavioral guidelines for patients with mild to moderate CKD. Aim 2: Conduct qualitative interviews and user testing among patients with CKD to obtain feedback on the design of the intervention. Aim 3: Conduct a prospective cohort feasibility trial to assess the feasibility and initial acceptability of the iControl CKD intervention.
Primary Outcome
Engagement with the intervention will be measured by calculating the proportion of participants responding to IVR calls or text tracking prompts over 1 month
Interventions
- BEHAVIORAL interactive Obesity Treatment Approach (iOTA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2020-02-20 |
| Phase | NA |
Why NCT03951363 stopped before completion
NCT03951363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which interactive Obesity Treatment Approach (iOTA) is the first listed.
NCT03951363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03951363 about?
NCT03951363 is a clinical study titled "iControl Chronic Kidney Disease". The proposed study is responsive to the call for obtaining enhanced preliminary data for an external grant resubmission. The goal is to demonstrate a novel approach using digital health tools to help preserve kidney function. The investigators aim to adapt a previous behavioral intervention and cond...
What is the current status of trial NCT03951363?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-05-13. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT03951363?
The interventions under investigation include: interactive Obesity Treatment Approach (iOTA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03951363?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03951363's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI